Search

everythinglearnresearchcommunity

for

Search:↓

Lichen planopilaris should be considered in diagnosing scarring hair loss in Black women.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Resveratrol shows health benefits but faces challenges in effectiveness and regulation.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

CCCA affects adolescents too, with genetic and environmental links, requiring careful diagnosis.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Dr. Min's method for eyebrow and eyelash transplantation is effective, with most hairs regrowing, and proper recovery is crucial for success.

Environmental pollutants can damage hair health and cause hair loss.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

Majocchi’s granuloma should be considered when rashes don't improve with typical treatments.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

The data suggests that dosing differences can help manage spasticity in patients with upper motor neuron dysfunction.

The document discusses various diseases of the outer ear, categorized by symptoms like redness, crusts, bumps, pus-filled lesions, lumps, ulcers, and hair loss.

Nonscarring alopecia has higher hair density than scarring alopecia, and hair density can help diagnose the type of alopecia.

Oral minoxidil can cause inflamed, ingrown hairs in the beard area.

The combination therapy effectively improved acne keloidalis nuchae.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

A handheld dermatoscope helps diagnose different types of hair loss effectively.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

HIV-1 may cause increased stem cell death in hair follicles, leading to hair loss.

New biopsy techniques and tools improve alopecia diagnosis, and both too much and too little selenium can cause hair loss.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Wearing a wig caused a woman's skin condition to worsen due to pressure from the wig's fasteners.

Pseudopelade of Brocq is hard to diagnose and treat, with limited effective options.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.